83 results on '"Welsh, A. W."'
Search Results
2. Patellofemoral stabilization with and without cartilage restoration
3. Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease
4. Substance use severity as a predictor for receiving medication for opioid use disorder among adolescents: An analysis of the 2019 TEDS
5. Is Single-Site Radiation Therapy Enough to Augment the Immune System and Enhance Immunotherapy for Metastatic Disease?
6. Hematologic variables associated with brain failure in patients with small-cell lung cancer
7. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers
8. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer
9. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control
10. Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer
11. Demographic and socioeconomic correlates to buprenorphine access in pharmacies.
12. Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study.
13. Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease.
14. Ex vivo delineation of placental angioarchitecture with the microbubble contrast agent Levovist
15. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
16. Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.
17. Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies.
18. Feasibility of image registration and fusion for evaluation of structure and perfusion of the entire second trimester placenta by three-dimensional power Doppler ultrasound.
19. Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.
20. Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.
21. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
22. Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy.
23. Automated Visualization and Quantification of Spiral Artery Blood Flow Entering the First-Trimester Placenta, Using 3-D Power Doppler Ultrasound.
24. Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.
25. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial.
26. Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.
27. Use of Simultaneous Radiation Boost Achieves High Control Rates in Patients With Non-Small-Cell Lung Cancer Who Are Not Candidates for Surgery or Conventional Chemoradiation.
28. Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement.
29. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.
30. Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?
31. The “Volumetric” Pulsatility Index as Evaluated by Spatiotemporal Imaging Correlation (STIC): A Preliminary Description of a Novel Technique, Its Application to the Endometrium and an Evaluation of Its Reproducibility
32. Rad51 Protein Expression and Survival in Patients with Glioblastoma Multiforme
33. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
34. Adolescent substance use: Challenges and opportunities related to COVID-19.
35. The Influence of Body Mass Index (BMI) >30 on Outcomes and Complications Following Medial Patellofemoral Ligament (MPFL) Reconstruction.
36. Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes.
37. Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy.
38. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
39. Re: Spatio-Temporal Imaging Correlation (STIC): Technical Notes About STIC Triggering and Choosing Between Power Doppler or High-Definition Color Flow
40. Su1971 Is a Repeat Endoscopy (EGD) Necessary When Referred for Staging of Newly Diagnosed Esophageal Cancer?: A Comparison of Cancer Specialty Institution (CSI) With Other Institutions (Osf).
41. A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases.
42. Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials.
43. Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC.
44. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
45. Use of Multi-Site Radiation Therapy for Systemic Disease Control.
46. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials.
47. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
48. Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy.
49. Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure.
50. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.